Media
NARCAN® Inventor on America’s Opioid Crisis – HLN
May 14, 2018 – Opiant CEO Dr. Roger Crystal discusses the fentanyl threat and the Company’s work to combat the opioid crisis.
New Fentanyl Overdose Nasal Spray – Fox Business with Varney & Co.
February 13, 2018 – Opiant CEO Dr. Roger Crystal discusses the Company’s work on a new nasal spray for opioid overdose that targets longer-acting and more potent synthetic opioids, including fentanyl.
New Data Supports Feasibility of New Heroin Vaccine – Mornings with Maria
December 20, 2017 – Opiant CEO Dr. Roger Crystal addresses the opioid crisis, the role of NARCAN® Nasal Spray and the Company’s other work in addiction, including heroin and alcohol.
America’s Opioid Crisis and Opiant Pharmaceuticals – Bay Sunday
November 5, 2017 – Opiant CEO Dr. Roger Crystal addresses addiction and the opioid crisis, the role of NARCAN® Nasal Spray, and the early work on a heroin vaccine.
Pharmaceutical Company Looks to Stop Heroin Addiction Before it Starts – Fox Business
October 26, 2017 – Opiant CEO Dr. Roger Crystal discusses the Company’s role in combating addiction and the opioid crisis, a “public health emergency” as declared by President Trump.
A Call to Washington from the Pharma Industry – an Op-ed by CEO Roger Crystal
October 6, 2017 – Opiant CEO Dr. Roger Crystal calls on Washington to partner with the pharma industry to tackle the opioid crisis.
Opioids, Doctors and Drug Addiction – KCRW Radio
September 29, 2017 – Opiant CEO Dr. Roger Crystal speaks with radio station KCRW about opioids, doctors and drug addiction.
Meeting of the President’s Commission on Combating Drug Addiction and Opioid Crisis
September 27, 2017 – Opiant CEO Dr. Roger Crystal testifies before the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
Mother Who Lost Her Daughter to Opioid Crisis Speaks Out – Fox News
August 11, 2017 – Opiant CEO Dr. Roger Crystal discusses the opioid crisis being declared a national emergency by President Trump.
Opiant Pharmaceuticals Looks to Create a Heroin Vaccine and Treat Addictions – The Street
July 28, 2017 – Opiant Pharmaceuticals Inc. is best known today for its NARCAN® Nasal Spray used to treat opioid overdoses. But CEO Roger Crystal hopes to make overdoses a thing of the past for most addicts by developing a vaccine that can end heroin dependence.